Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT)

Jolanta Marucha , Anna Tylki-Szymańska , Joanna Jakóbkiewicz-Banecka , Ewa Piotrowska , Anna Kloska , Barbara Czartoryska , Grzegorz Węgrzyn


Author Jolanta Marucha - [Instytut Pomnik-Centrum Zdrowia Dziecka]
Jolanta Marucha,,
, Anna Tylki-Szymańska - [Instytut Pomnik-Centrum Zdrowia Dziecka]
Anna Tylki-Szymańska,,
, Joanna Jakóbkiewicz-Banecka (FB / DMBG)
Joanna Jakóbkiewicz-Banecka,,
- Katedra Biologii i Genetyki Medycznej
, Ewa Piotrowska (FB / DMoB)
Ewa Piotrowska,,
- Department of Molecular Biology
, Anna Kloska (FB / DMBG)
Anna Kloska,,
- Katedra Biologii i Genetyki Medycznej
, Barbara Czartoryska - [Institute of Psychiatry and Neurology, Warszawa]
Barbara Czartoryska,,
, Grzegorz Węgrzyn (FB / DMoB)
Grzegorz Węgrzyn,,
- Department of Molecular Biology
Journal seriesAmerican Journal of Medical Genetics Part A, ISSN 1552-4825, (A 20 pkt)
Issue year2011
Keywords in Englishgene expression-targeted isoflavone therapy, genistein, Hunter disease, mucopolysaccharidoses, joint motion, substrate reduction therapy
Languageen angielski
Score (nominal)25
Publication indicators Scopus Citations = 25; WoS Citations = 24; WoS Impact Factor: 2011 = 2.391 (2) - 2011=2.549 (5)
Citation count*30 (2019-04-20)
Share Share

Get link to the record

* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.